Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Health and Quality of Life Outcomes
Published in: Health and Quality of Life Outcomes 1/2017

Open Access 01-01-2017 | Research

Valuation of the EQ-5D-5L with composite time trade-off for the German population – an exploratory study

Authors: Kristina Ludwig, J.-Matthias Graf von der Schulenburg, Wolfgang Greiner

Published in: Health and Quality of Life Outcomes | Issue 1/2017

Login to get access

Abstract

Background

The EuroQol Group has extended the severity levels of the EQ-5D from three to five (EQ-5D-5L). There are valuation studies worldwide planned in order to convert the EQ-5D-5L health states into a single preference-based summary score based on country-specific value sets of social health status preference valuations. The EuroQol Group developed an internationally standardised EQ-5D-5L valuation protocol. Based on the experiences of the first wave of valuation studies applying the protocol, a number of modifications to the implementation of composite time trade-off (cTTO) were proposed and tested in an exploratory study in Germany.

Methods

The aim of the study is to test the improved EQ-5D-5L valuation protocol 1.1 and the implementation of three modifications: (1) introduction of ranking task, (2) separating time trade-off (TTO) tasks for health states “Better Than Dead“(BTD)/“Worse Than Dead” (WTD), (3) allow for removal of problematic valuations from the cTTO data (the feedback module). Data were collected in computer assisted personal interviews with 200 members of the German general public.

Results

In comparison to the first wave of valuation studies a higher data quality can be observed in both study arms: increasing number of WTD valuations, reduced inconsistencies for health state 55555 as well as higher values for mild health states. Comparing both study arms, mean observed cTTO value for severity 6 is higher in the test arm. The proportion of inconsistent cTTO responses is lower in the test arm than in the control arm and is further reduced by the feedback module. The ranking task prolongs the interview without the desired effect.

Conclusions

Both study arms yielded higher data quality in comparison to the first wave of EQ-5D-5L valuation studies. The valuation protocol combined with an intensive interviewer training and close data monitoring showed a high feasibility and acceptability to the respondents of the general population as well as the interviewers in Germany. Based on the results of this study and other countries, the separation of TTO tasks for health states BTD/WTD and the feedback module will be implemented in the valuation study for the EQ-5D-5L for Germany.
Literature
1.
Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33(5):337–43.CrossRefPubMed
2.
Greiner W. Der EQ-5D der EuroQol-Gruppe. In: Schöffski O, Graf von der Schulenburg JM, editors. Gesundheitsökonomische Evaluationen. 4th ed. Berlin: Springer; 2012. p. 411–22.
3.
Devlin NJ, Krabbe PFM. The development of new research methods for the valuation of EQ-5D-5L. Eur J Health Econ. 2013;14 Suppl 1:S1–3.
4.
Herdman M, Gudex C, Lloyd A, Janssen MF, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727–36.
5.
Szende A, Oppe M, Devlin N. EQ-5D value sets: inventory, comparative review, and user guide. Dordrecht: Springer; 2007.CrossRef
6.
van Hout B, Janssen MF, Feng Y-S, Kohlmann T, Busschbach J, Golicki D, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012;15:708–15.
7.
Greiner W, Claes C, Busschbach JJV, Graf von der Schulenburg JM. Validating the EQ-5D with time trade off for the German population. Eur J Health Econ. 2005;6:124–30.
8.
Oppe M, Devlin NJ, van Hout B, Krabbe PFM, de Charro F. A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol. Value Health. 2014;17:445–53.
9.
Shah K, Rand-Hendriksen K, Ramos JM, Prause AJ, Stolk E. Improving the quality of data collected in EQ-5D-5L valuation studies: a summary of the EQ-VT research methodology programme. In: Proceedings of the 31st Scientific Plenary Meeting of the EuroQol Group. 2014. p. 1–18.
10.
11.
Versteegh MM, Vermeulen KM, Evers SMAA, de Wit GA, Prenger R, Stolk EA. Dutch tariff for the five-level version of EQ-5D. Value Health. 2016;19:343–52.CrossRef
12.
Oppe M, Rand-Hendriksen K, Shah K, Ramos-Goñi JM, Luo N. EuroQol protocolsfor time trade-off valuation of health outcomes. Pharmacoeconomics. 2016;34:993–1004.
13.
14.
15.
Attema AE, Edelaar-Peeters Y, Versteegh MM, Stolk EA. Time trade-off: one methodology, different methods. Eur J Health Econ. 2013;14 Suppl 1:S53–64.CrossRefPubMed
16.
Devlin NJ, Tsuchiya A, Buckingham K, Tilling C. A uniform time trade off method for states better and worse than dead: feasibility study of the ‘lead time’ approach. Health Econ. 2011;20:348–61.CrossRefPubMed
17.
Janssen BMF, Oppe M, Versteegh MM, Stolk EA. Introducing the composite time trade-off: a test of feasibility and face validity. Eur J Health Econ. 2013;14 Suppl 1:S5–13.CrossRefPubMed
18.
Bansback N, Brazier J, Tsuchiya A, Anis A. Using a discrete choice experiment to estimate health state utility values. J Health Econ. 2012;31:306–18.CrossRefPubMed
19.
Stolk EA, Oppe M, Scalone L, Krabbe PFM. Discrete choice modeling for the quantification of health states: the case of the EQ-5D. Value Health. 2010;13(8):1005–13.CrossRefPubMed
20.
Brazier J, Ratcliffe J, Salomon JA, Tsuchiya A. Measuring and valuing health benefits for economic evaluation. Oxford: Oxford University Press; 2007.
21.
Ramos-Goñi JM, Rand-Hendriksen K, Pinto-Prades JL. Does the introduction of the ranking task in valuation studies improve data quality and reduce inconsistencies? The case of the EQ-5D-5L. Value Health. 2016;19:478–86.
22.
Stolk EA, Visser M, van Busschbach J. Test of two modifications of the EQ-VT to improve the consistency of TTO data. Stockholm; EuroQol Group. 2014.
23.
Federal Statistical Office. Mikrozensus. Bevölkerung und Erwerbstätigkeit. Stand und Entwicklung der Erwerbstätigkeit in Deutschland 2014. Wiesbaden: Federal Statistical Office; 2015.
24.
25.
Attema AE, Brouwer WBF. Deriving time discounting correction factors for TTO tariffs. Health Econ. 2014;23:410–25.CrossRefPubMed
Metadata
Title
Valuation of the EQ-5D-5L with composite time trade-off for the German population – an exploratory study
Authors
Kristina Ludwig
J.-Matthias Graf von der Schulenburg
Wolfgang Greiner
Publication date
01-01-2017
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2017
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-017-0617-9

Other articles of this Issue 1/2017

Health and Quality of Life Outcomes 1/2017 Go to the issue

Research

Beyond quality of life: a cross sectional study on the mental health of patients with chronic kidney disease undergoing dialysis and their caregivers

Research

Benefits of different intensity of aerobic exercise in modulating body composition among obese young adults: a pilot randomized controlled trial

Research

Health-related quality of life and influencing factors among migrant children in Shaoxing, China

Research

International comparison of experience-based health state values at the population level

Research

The impact of resilience on psychological outcomes in women with threatened premature labor and spouses: a cross-sectional study in Southwest China

Research

Development of a Microsoft Excel tool for applying a factor retention criterion of a dimension coefficient to a survey on patient safety culture